Canada Generic Drug Market Report 2017: Driven by Continuous Expiration of Drug Patents, Rising Aging Population & Increasing Prevalence of Chronic Diseases - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report to their offering.

Canada represents the world's ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multi-billion dollar industry in Canada.

The report entitled Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022 represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Companies Mentioned

  • Actavis
  • Apotex Inc.
  • Hospira
  • Mylan
  • Novartis
  • Pharmascience Inc.
  • Ranbaxy Pharmaceuticals Canada
  • Sandoz Canada
  • Taro Pharmaceuticals
  • Teva Pharmaceutical Ltd.

Key Topics Covered:

1 Preface

2 Research Methodology and Market Definitions

3 Executive Summary

4 Canada Generic Drug Market: Introduction

5 Why is the Generic Drug Market So Lucrative in Canada

6 Global Generic Drug Market

7 Canada Generic Drug Market

8 SWOT Analysis

9 Value Chain Analysis

10 Pricing Mechanism and Profit Margins at Various Levels of Supply Chain

11 Porter's Five Forces Analysis

12 Canada Generic Drug Market: Competitive Landscape

13 Canada Generic Drug Market: Key Success Factors

14 Canada Generic Drug Market: Road Blocks

15 Canada Generic Drug Market: Regulatory Framework

16 Generic Drug Manufacturing Process

17 Canada Generic Drug Market - Key Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/msc7k7/canada_generic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Generic Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Generic Drugs